Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

05. Juli 2016 07:00 ET | Quelle: Sunesis Pharmaceuticals Inc

Sunesis Pharmaceuticals to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference

SOUTH SAN FRANCISCO, Calif., July 05, 2016 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that Daniel Swisher, Chief Executive Officer of Sunesis, will present at...
13. Juni 2016 07:00 ET | Quelle: Sunesis Pharmaceuticals Inc

Sunesis Pharmaceuticals Announces Presentation of Positive Results from MD Anderson Sponsored Trial in Frontline Elderly AML and MDS at the EHA Annual Meeting

SOUTH SAN FRANCISCO, Calif., June 13, 2016 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals (NASDAQ:SNSS) today announced the presentation of updated results from an ongoing Phase 1b/2 University of...
06. Juni 2016 09:12 ET | Quelle: Sunesis Pharmaceuticals, Inc.

Sunesis Announces Study Examining the Value of Complete Remission Prior to HCT in Patients with AML Presented at 2016 ASCO Annual Meeting

SOUTH SAN FRANCISCO, Calif., June 06, 2016 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) today announced the presentation of results from a study conducted by the Center for...
01. Juni 2016 07:00 ET | Quelle: Sunesis Pharmaceuticals, Inc.

Sunesis Pharmaceuticals Appoints Linda Neuman, M.D., as Vice President, Clinical Development

SOUTH SAN FRANCISCO, Calif., June 01, 2016 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) today announced that Linda Neuman, M.D., has been appointed to the role of Vice...
25. Mai 2016 09:00 ET | Quelle: Sunesis Pharmaceuticals, Inc.

Sunesis Pharmaceuticals Announces Support of First-Ever Acute Myeloid Leukemia Awareness Month in June

Sunesis Provides Educational Grant to Support Campaign Sponsor CancerCare SOUTH SAN FRANCISCO, Calif., May 25, 2016 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today...
19. Mai 2016 07:28 ET | Quelle: Sunesis Pharmaceuticals, Inc.

Sunesis Pharmaceuticals Announces Oral Presentation on Vosaroxin at the 21st Congress of the European Hematology Association

SOUTH SAN FRANCISCO, Calif., May 19, 2016 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) today announced an oral presentation on vosaroxin at the 21st Congress of the European...
18. Mai 2016 07:00 ET | Quelle: Sunesis Pharmaceuticals, Inc.

Sunesis to Present at the 2016 UBS Global Healthcare Conference

SOUTH SAN FRANCISCO, Calif., May 18, 2016 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that Daniel Swisher, Chief Executive Officer of Sunesis, will present at...
05. Mai 2016 07:00 ET | Quelle: Sunesis Pharmaceuticals, Inc.

Sunesis Pharmaceuticals Reports First Quarter 2016 Financial Results and Recent Highlights

SOUTH SAN FRANCISCO, Calif., May 05, 2016 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today reported financial results for the first quarter ended March 31, 2016. Loss from...
28. April 2016 07:00 ET | Quelle: Sunesis Pharmaceuticals, Inc.

Sunesis to Host Conference Call on May 5th to Discuss First Quarter 2016 Financial Results and Recent Highlights

SOUTH SAN FRANCISCO, Calif., April 28, 2016 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) today announced that it will host a conference call on Thursday, May 5, 2016 at 11:00...
05. April 2016 07:00 ET | Quelle: Sunesis Pharmaceuticals, Inc.

Sunesis Pharmaceuticals to Present at the 15th Annual Needham Healthcare Conference

SOUTH SAN FRANCISCO, Calif., April 05, 2016 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that Daniel Swisher, Chief Executive Officer of Sunesis, will present at...

Vorherige Seite